JEJames Eberwine

James Eberwine

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


James Eberwine has a total of 63 co-authors. Here are the top co-authors by number of shared publications:

  • Kevin Miyashiro

    Department of Pharmacology, University of Pennsylvania Medical Center, Philadelphia, PA 19104, USA

    4 shared publications
  • Christy Job

    Department of Pharmacology, University of Pennsylvania Medical Center, Philadelphia, PA 19104-6058, USA

    3 shared publications
  • Jai-Yoon Sul

    Department of Pharmacology, University of Pennsylvania, Philadelphia, Pennsylvania 19104

    3 shared publications
  • Janet Estee Kacharmina

    Departments of Pharmacology and Psychiatry

    3 shared publications
  • Tracy McIntosh

    Department of Neurosurgery, University of Pennsylvania Medical School, 36th and Hamilton Walk, Philadelphia, PA 19104, USA

    2 shared publications
  • Arezou Sarabi

    Department of Pharmacology, University of Pennsylvania Medical School, 36th and Hamilton Walk, Philadelphia, PA 19104, USA

    1 shared publication

Latest Publications

  • Open Access

    Single-Neuron Isolation for RNA Analysis Using Pipette Capture and Laser Capture Microdissection

    by Ditte Lovatt, Thomas Bell, James Eberwine

    The field of single-cell analysis has greatly benefitted from recent technological advances allowing scientists to study genomes, transcriptomes, proteomes, and metabolomes at the single-cell level. Transcriptomics allows a unique window into cell function and is especially useful for studying global variability among single cells of seemingly the same type. Generating transcriptome data from RNA samples has become increasingly easy and can be done using either microarray or RNA-Seq techniques. RNA isolation is the first step of transcriptomics. Numerous RNA isolation procedures exist and differ with respect to the type and number of cells from which they are capable of isolating RNA. Although it is trivial to isolate RNA from bulk tissue or culture plates, sophisticated methods are required to capture RNA from single cells in a pool of cells or in intact tissue. We describe here the protocols used for isolating the soma of single neurons in cultures and in tissue slices using the pipette capture and the PALM or laser capture microdissection (LCM) approaches, respectively. LCM was developed to isolate cells from tissue sections primarily for pathological tissue analysis. LCM can be used to isolate individual cells or groups of cells from ethanol or paraffin-embedded formalin-fixed tissue sections and dissociated tissue cultures. The soma isolates from either technique can subsequently be used for RNA amplification procedures and transcriptome analysis. These procedures can also be adapted to other cell types in cultures and tissue sections and can be used on neuronal subcellular structures, such as dendrites.


  • Open Access

    Single Cell/Cellular Subregion-Targeted Phototransfection

    by Jaehee Lee, Jai-Yoon Sul, James H. Eberwine

    Introduction of exogenous genetic material, such as DNA, mRNA, siRNA, or miRNA, into cells is routinely performed using one of the many different standardized methods, including lipid-mediated transfection, electroporation, and microinjection to identify their biological function. The ability to control the location and amount of nucleic acids introduced into a cell is particularly important for studying polarized cells such as neurons. Lipid-mediated transfection is simple and fast but lacks regional specificity of delivery, whereas microinjection is regionally specific but labor intensive. To overcome these obstacles, we developed and use the method of phototransfection. In this method, a conventional microscope with a high-power pulse laser of any wavelength is able with minimal destructiveness to induce transient pores into the plasma membrane of the target cell, which remain open long enough to allow exogenous genetic material to diffuse into the cytosol before the pore closes due to membrane dynamics. The technique is not limited by choice of cell type or by genetic material to be introduced, and for RNA allows transfection of multiple mRNAs simultaneously in any desired amount or ratio. Further, phototransfection allows the target area to be a specific cell in a population of cells or a specific subregion within a cell. This protocol summarizes the key steps for performing phototransfection, provides a guide to optimization, and uses as an example green fluorescent protein (GFP) mRNA transfection within a single neuronal process.

  • Transcriptome transfer provides a model for understanding the phenotype of cardiomyocytes

    by Tae Kyung Kim, Jai-Yoon Sul, Nataliya B. Peternko, Jae Hee Lee, Miler Lee, Vickas V. Patel, Junhyong Kim, James H. Eberwine

    We show that the transfer of the adult ventricular myocyte (AVM) transcriptome into either a fibroblast or an astrocyte converts the host cell into a cardiomyocyte. Transcriptome-effected cardiomyocytes (tCardiomyocytes) display morphologies, immunocytochemical properties, and expression profiles of postnatal cardiomyocytes. Cell morphology analysis shows that tCardiomyoctes are elongated and have a similar length-to-width ratio as AVMs. These global phenotypic changes occur in a time-dependent manner and confer electroexcitability to the tCardiomyocytes. tCardiomyocyte generation does not require continuous overexpression of specific transcription factors; for example, the expression level of transcription factor Mef2c is higher in tCardiomyocytes than in fibroblasts, but similar in tCardiomyocytes and AVMs. These data highlight the dominant role of the gene expression profile in developing and maintaining cellular phenotype. The transcriptome-induced phenotype remodeling–generated tCardiomyocyte has significant implications for understanding and modulating cardiac disease development.


  • Cytoplasmic BK Ca channel intron-containing mRNAs contribute to the intrinsic excitability of hippocampal neurons

    by Thomas J. Bell, Kevin Y. Miyashiro, Jai-Yoon Sul, Ronald McCullough, Peter T. Buckley, Jeanine Jochems, David F. Meaney, Phil Haydon, Charles Cantor, Thomas D. Parsons, et al.

    High single-channel conductance K + channels, which respond jointly to membrane depolarization and micromolar concentrations of intracellular Ca 2+ ions, arise from extensive cell-specific alternative splicing of pore-forming α-subunit mRNAs. Here, we report the discovery of an endogenous BK Ca channel α-subunit intron-containing mRNA in the cytoplasm of hippocampal neurons. This partially processed mRNA, which comprises ≈10% of the total BK Ca channel α-subunit mRNAs, is distributed in a gradient throughout the somatodendritic space. We selectively reduced endogenous cytoplasmic levels of this intron-containing transcript by RNA interference without altering levels of the mature splice forms of the BK Ca channel mRNAs. In doing so, we could demonstrate that changes in a unique BK Ca channel α-subunit intron-containing splice variant mRNA can greatly impact the distribution of the BK Ca channel protein to dendritic spines and intrinsic firing properties of hippocampal neurons. These data suggest a new regulatory mechanism for modulating the membrane properties and ion channel gradients of hippocampal neurons.


  • Elk-1 associates with the mitochondrial permeability transition pore complex in neurons

    by L. E. Barrett, E. J. Van Bockstaele, J. Y. Sul, H. Takano, P. G. Haydon, J. H. Eberwine

    The nuclear transcription factor E-26-like protein 1 (Elk-1) is thought to impact neuronal differentiation [Sharrocks, A. D. (2001) Nat. Rev. Mol. Cell Biol. 2, 827–837], cell proliferation [Sharrocks, A. D. (2002) Biochem. Soc. Trans. 30, 1–9], tumorigenesis [Chai, Y. L., Chipitsyna, G., Cui, J., Liao, B., Liu, S., Aysola, K., Yezdani, M., Reddy, E. S. P. & Rao, V. N. (2001) Oncogene 20, 1357–1367], and apoptosis [Shao, N., Chai, Y., Cui, J., Wang, N., Aysola, K., Reddy, E. S. P. & Rao, V. N. (1998) Oncogene 17, 527–532]. In addition to its nuclear localization, Elk-1 is found throughout the cytoplasm, including localization in neuronal dendrites [Sgambato, V., Vanhoutte, P., Pages, C., Rogard, M., Hipskind, R., Besson, M. J. & Caboche, J. (1998) J. Neurosci. 18, 214–226], raising the possibility that Elk-1 may have alternative extranuclear functions in neurons. Using coimmunoprecipitation and reciprocal coimmunoprecipitation from adult rat brain, we found an association between Elk-1 protein and the mitochondrial permeability transition pore complex (PTP), a structure involved in both apoptotic and necrotic cell death. Electron microscopy in adult rat brain sections confirmed this association with mitochondria. Elk-1 was also identified from purified mitochondrial fractions by using Western blotting, and Elk-1 increased its association with mitochondria following proapoptotic stimuli. Consistent with a role for Elk-1 in neuron viability, overexpression of Elk-1 in primary neurons decreased cell viability, whereas Elk-1 siRNA-mediated knockdown increased cell viability. This decrease in viability induced by Elk-1 overexpression was blocked with application of a PTP inhibitor. These results show an association of the nuclear transcription factor Elk-1 with the mitochondrial PTP and suggest an additional extranuclear function for Elk-1 in neurons.


  • RNA splicing capability of live neuronal dendrites

    by J. Glanzer, K. Y. Miyashiro, J.-Y. Sul, L. Barrett, B. Belt, P. Haydon, J. Eberwine

    Dendrites are specialized extensions of the neuronal soma that contain components of the cellular machinery involved in RNA and protein metabolism. Several dendritically localized proteins are associated with the precursor-mRNA (pre-mRNA) splicing complex, or spliceosome. Although some spliceosome-related, RNA-binding proteins are known to subserve separate cytoplasmic functions when moving between the nucleus and cytoplasm, little is known about the pre-mRNA splicing capacity of intact dendrites. Here, we demonstrate the presence and functionality of pre-mRNA-splicing components in dendrites. When isolated dendrites are transfected with a chicken δ-crystallin pre-mRNA or luciferase reporter pre-mRNA, splicing junctions clustered at or near expected splice sites are observed. Additionally, in vitro synaptoneurosome experiments show that this subcellular fraction contains a similar complement of splicing factors that is capable of splicing chicken δ-crystallin pre-mRNA. These observations suggest that pre-mRNA-splicing factors found in the dendroplasm retain the potential to promote pre-mRNA splicing.


  • Fragile X syndrome: (What's) lost in translation?

    by Kevin Miyashiro, James Eberwine

    The changing nature of synaptic function in neuronal dendrites during development is one of a myriad of phenomenological observations that have fascinated neurobiologists for some time. In the case of fragile X syndrome (FXS), neurons exhibit long, spindly dendritic spines that appear to be morphologically immature (1). As with all dendritic spines, these FXR spines typically house elements of the postsynaptic density juxtaposed with components of the translation apparatus (2). A dominant mutation in the FMR1 gene gives rise to FXS through the elimination of FMR1 RNA. This gene encodes the fragile X mental retardation protein (FMRP), which is a RNA-binding protein. By using in vitro assays, FMRP has been proposed to be involved in modulating translation through its binding to cellular RNAs and ribosomes (3). In early studies, Weiler et al. (4) showed that the FMR1 RNA was localized in dendrites and that its translation could be modulated by group 1 metabotropic glutamate receptor (Gp1 mGluR) agonists. Subsequent studies have extended, and begun to clarify, the potential aftereffects of such events and their impact on normal cellular functioning, as well as FXS. In this issue of PNAS, Weiler et al. (5) have taken an important step in showing the complexity of FMRP-mediated translational control. By using cortical synaptoneurosome preparations, Weiler et al. (5) demonstrate that Gp1 mGluR (i.e., mGluR1 and mGluR5) activation has …


  • Single neurons as experimental systems in molecular biology

    by David Hinkle, Jason Glanzer, Arezou Sarabi, Tiina Pajunen, Jennifer Zielinski, Brian Belt, Kevin Miyashiro, Tracy McIntosh, James Eberwine


  • Open Access

    Expression profiling of small cellular samples in cancer: less is more

    by J G Glanzer, J H Eberwine

    Expression profiling of tumours from cancer patients has uncovered several genes that are critically important in the progression of a normal cell to an oncogenic phenotype. Leading the way in these discoveries is the use of microarrays, a technology that is currently in transition from basic science applications to use in the clinic. Microarrays can determine the global gene regulation of an individual cancer, which may be useful in formulating an individualised therapy for the patient. Currently, cells used in breast cancer microarray studies often come from either homogenous cultures or heterogeneous biopsy samples. Both cell sources are at a disadvantage in determining the most accurate gene profile of cancer, which often consists of multiple subspecies of cancerous cells within a background of normal cells. Therefore, acquisition of small, but highly specific biopsies for analysis may be required for an accurate expression analysis of the disease. Amplification methods, such as polymerase chain reaction (PCR) and amplified antisense RNA (aRNA) amplification, have been used to amplify the mRNA signal from very small samples, which can then be used for microarray analysis. In this study, we describe the acquisition, amplification, and analysis of very small samples (<10 000 cells) for expression analysis and demonstrate that the ultimate resolution of cancer expression analysis, one cell, is both feasible and practical.


  • Open Access

    Gene Expression Profile for Schizophrenia

    by Scott E. Hemby, Stephen D. Ginsberg, Brian Brunk, Steven E. Arnold, John Q. Trojanowski, James H. Eberwine

    SCHIZOPHRENIA IS a chronic, debilitating psychiatric illness affecting approximately 1% of the general population. Clinical manifestations appear during late adolescence to early adulthood. Characteristic features of schizophrenia include a mixture of positive (distortions of inferential thought, perception, language/communication, and behavioral monitoring) and negative (blunted affect, alogia, and avolition) symptoms.1 The temporal lobe, including the hippocampus, subiculum, and entorhinal cortex (EC), is a primary brain region associated with schizophrenia. The EC is integral to the function of the hippocampus, regulating the interaction of the hippocampus with other brain regions. Disruption of neuronal functioning in this region could affect information processing between the hippocampus and various cortical areas. Dysregulation of temporal lobe function is associated with symptoms that are similar to those found in individuals diagnosed as having schizophrenia. For example, results of functional neuroimaging studies and neuropsychological assessment of patients with schizophrenia report significant deficits in temporal lobe function.2 Results of most structural imaging studies in schizophrenia indicate a slight but significant reduction in hippocampal volume,3-11 although other studies failed to observe these differences.12-14 A relative paucity of neurodegeneration, cell death, or gliosis is observed in temporal lobe structures in schizophrenic brains.15,16